Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks

Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction

(2009) Marc-Michael Zaruba et al.   Cell Stem Cell

Hematopoietic growth factor mimetics: From concept to clinic

(2009) Michelle Perugini et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Thrombopoietin and Thrombopoietin Mimetics in the Treatment of Thrombocytopenia

(2008) David J. Kuter   Annual Review of Medicine

Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model

(2008) Ping Xiang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction

(2008) Ankur Saxena et al.   CIRCULATION

Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6kinase signaling pathway

(2008) Masamichi Eguchi et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

(2008) Pál Pacher et al.   Nature Protocols

Improved Granulocyte Colony-Stimulating Factor Mobilization of Hemopoietic Progenitors Using Cytokine Combinations in Primates

(2008) Stephen R. Larsen et al.   STEM CELLS

Roles of PKA, PI3K, and cPLA2 in the NO-mediated negative inotropic effect of β2-adrenoceptor agonists in guinea pig right papillary muscles

(2007) Fabien A. Faucher et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY